7741.T · Intrinsic value
Is HOYA Corporation (7741.T) overvalued or undervalued?
HOYA Corporation (7741.T) trades at the delayed market price of ¥25,580.00 a share. That price already implies revenue growth of 22.6% a year for 5 years. TickerWorth's fair value is ¥16,569.98 a share (54% above fair value), as of Oct 19, 2026. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from market data · Updated Oct 19, 2026 · How these pages are made
Is 7741.T overvalued?
- Fair value
- ¥16,569.98
- Market price
- ¥25,580.00
- Downside to fair value
- 35.2%
- Verdict
- 54% above fair value
Reverse DCF: Today's price implies revenue growth of 22.6% a year for 5 years; our model assumes 10.0% a year on average over the same horizon.
What is 7741.T's TickerWorth Score?
Middle of the pack — real strengths and real weaknesses
Compared with Healthcare companies in Japan
Its strongest point: a profitable, high-quality business. Its weakest: looks expensive on the numbers.
- Value · 30 of 100
Cheaper than 30% of Healthcare companies worldwide
- Price vs worth · 22 of 100
- Quality · 74 of 100
More profitable than 74% of Healthcare companies worldwide
- Financial health · 67 of 100
Financially stronger than 67% of Healthcare companies worldwide
- Growth · 49 of 100
Growing faster than 49% of Healthcare companies worldwide
- Momentum · 47 of 100
Outperformed 47% of Healthcare companies worldwide over the past year
Confidence: High confidence · Scored
Get the Undervalued Company of the Week.
7741.T DCF valuation: what the price assumes
At a recent price of ¥25,580, HOYA Corporation (7741.T) trades 54% above TickerWorth's blended fair value of ¥16,570 per share — a discounted-cash-flow model cross-checked against peer multiples and asset value — meaning the market currently prices 7741.T overvalued vs our estimate of what the business is intrinsically worth. Our fair value sits below the market, an implied -35.2% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.
Read the full reasoning
One of the lenses behind that blended figure is a discounted-cash-flow model, which on its own values 7741.T at about ¥15,238 per share. The rest of this page walks through that DCF — its assumptions, reverse-DCF and discount-rate sensitivity — because it is the auditable anchor of the blend.
The valuation discounts HOYA Corporation's projected free cash flows at a weighted-average cost of capital (WACC) of 10.3%, with a long-run terminal growth rate of 2.5%. About 71% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 22.6% annual revenue growth for 7741.T. Our base case instead compounds to about 10.0% a year over the same forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, 7741.T's modeled DCF value ranges from about ¥12,171 to ¥21,148 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what HOYA Corporation would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of 7741.T's intrinsic value. Figures update as new filings and prices come in.
Every input behind 7741.T's DCF
| Input | Value |
|---|---|
| Base-year revenueLive feed — totalRevenue (TTM) | ¥983,639,980,000 |
| Base EBIT marginComputed — trailing operatingMargins, held roughly flat | 32.4% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 16% → 13% → 10% → 7% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.2% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 1.10 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesLive feed — sharesOutstanding | 334M |
| Market priceDelayed quote · as of 2026-10-19 17:02 UTC | ¥25,580 |
Change 7741.T's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does HOYA Corporation do?
What does it do?
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It operates in the Medical Instruments & Supplies industry (Healthcare sector), headquartered in Japan. The company employs roughly 37,752 people.
How does it make money?
The business turns 983.6B in annual revenue into profit. Out of every $100 of sales, about $32 is left as operating profit (operating margin of 32.4%), after a 48% gross margin on the products/services it sells. After all costs, taxes and interest, 27.2% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries heavy debt (4.4× equity), comfortably covers its short-term bills (4.9× current ratio), and is currently profitable.
7741.T insider trading
Insider filings are available for US-listed companies only.
Common questions
What is 7741.T's intrinsic value?
TickerWorth's blended fair value for HOYA Corporation (7741.T) is ¥16,570 per share, versus a market price of ¥25,580 (54% above fair value).
Is 7741.T overvalued or undervalued?
On our blended fair value 7741.T looks overvalued vs fair value at ¥25,580. This is an educational estimate, not advice.
What discount rate is used for 7741.T?
A WACC of 10.3% and a terminal growth rate of 2.5%.
Is HOYA stock undervalued?
TickerWorth's fair value for HOYA Corporation (7741.T) is ¥16,569.98 against a market price of ¥25,580.00. Our read: 54% above fair value. This is a model estimate, not investment advice.
HOYA (7741.T) DCF valuation and fair value
Our fair value for HOYA Corporation (7741.T) is ¥16,569.98, built on a 10.3% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into HOYA stock?
Today's price implies revenue growth of 22.6% a year for 5 years; our model assumes 10.0% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of ¥25,580.00. A model estimate, not investment advice.
HOYA (7741.T) insider trading
We have no recent SEC Form 4 insider filings on file for HOYA Corporation (7741.T). Form 4 covers US-listed companies only.
Stocks below our fair value instead
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.